Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Cancer Research

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10430101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor expression in breast cancer epithelium and stroma

  2005cited by this paper
• Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting.

  1997cited by this paper
• Insulin receptor what role in breast cancer?

  1997cited by this paper
• Insulin receptor expression and clinical outcome in node-negative breast cancer.

  1997cited by this paper
• Insulin-like Growth Factors and Cancer

  1995cited by this paper
• A functional assessment of insulin/insulin-like growth factor-I hybrid receptors.

  1995cited by this paper
• Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.

  1995cited by this paper
• The insulin-like growth factor I receptor: a key to tumor growth?

  1995cited by this paper
• Growth factors in breast cancer.

  1995cited by this paper
• Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.

  1994cited by this paper
• Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.

  1994cited by this paper
• Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification.

  1993cited by this paper
• Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

  1993cited by this paper
• Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.

  1993cited by this paper
• Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors.

  1993cited by this paper
• A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.

  1992cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• Insulin receptor expression and function in human breast cancer cell lines.

  1992cited by this paper
• A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.

  1992cited by this paper
• Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype.

  1991cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Insulin-like growth factor receptor expression and function in human breast cancer.

  1990cited by this paper
• Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

  1990cited by this paper
• The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras.

  1990cited by this paper
• Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells.

  1990cited by this paper
• Elevated insulin receptor content in human breast cancer.

  1990influential reference
• Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers.

  1989cited by this paper
• Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

  1989cited by this paper
• Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation.

  1987cited by this paper
• Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor.

  1986influential reference
• Purification of insulin-like growth factor I receptor from human placental membranes.

  1986cited by this paper
• Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.

  1985cited by this paper
• Isolation and growth of human mammary epithelial cells

  1985cited by this paper
• Monoclonal antibodies to receptors for insulin and somatomedin-C.

  1983cited by this paper
• Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.

  1982cited by this paper
• Tissue Culture Methods

  1980cited by this paper

• Using site-directed mutagenesis to further the understanding of insulin receptor-insulin like growth factor-1 receptor heterodimer structure

  2024cites this paper
• Insulin Receptor Loss Impairs Mammary Tumorigenesis in Mice

  2023cites this paper
• Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy

  2023cites this paper
• IGF-1R targeting in cancer – does sub-cellular localization matter?

  2023cites this paper
• The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis

  2023cites this paper
• Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators

  2022cites this paper
• Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis.

  2022cites this paper
• (Pro)renin receptor and insulin signaling regulate cell proliferation in MCF-7 breast cancer cells.

  2022cites this paper
• Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons

  2021cites this paper
• Diversity of insulin and IGF signaling in breast cancer: implications for therapy.

  2021cites this paper
• Obesity and Postmenopausal Hormone Receptor-positive Breast Cancer: Epidemiology and Mechanisms.

  2021cites this paper
• Immunoendocrine Dysregulation during Gestational Diabetes Mellitus: The Central Role of the Placenta

  2021cites this paper
• BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer

  2020cites this paper
• The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives

  2020cites this paper
• Aging interacts with tumor biology to produce major changes in the immune tumor microenvironment

  2020cites this paper
• Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?

  2020cites this paper
• Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug

  2020cites this paper
• Difficult to Heal Wounds Intralesional Insulin Therapy Trial

  2020cites this paper
• Metformin as an adjuvant in breast cancer treatment

  2019cites this paper
• Identification of a novel EphB4 phosphodegron regulated by the autocrine IGFII/IRA axis in malignant mesothelioma

  2019cites this paper
• Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor

  2018cites this paper
• Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors

  2018cites this paper
• Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer

  2018cites this paper
• The role of insulin-like growth factor system in the adrenocortical tumors.

  2018cites this paper
• Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats

  2018cites this paper
• The Effects of Exercise Training on Insulin Supply and Demand in Breast Cancer Survivors

  2017cites this paper
• Fundamental Pathways in Breast Cancer 1: Signaling from the Membrane

  2017cites this paper
• Insulin Receptor Isoforms in Physiology and Disease: An Updated View

  2017cites this paper
• Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide

  2017cites this paper
• Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells

  2017cites this paper
• Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?

  2017cites this paper
• Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer

  2017cites this paper
• Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer

  2017cites this paper
• Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups

  2016cites this paper
• Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells.

  2016cites this paper
• Insulin, insulin receptors, and cancer

  2016cites this paper
• Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival

  2016influential citation
• The regulatory mechanisms of enhancing IGF-1R expression and activity and the impact on therapy resistance of melanoma cells

  2016cites this paper
• Metformin may protect nondiabetic breast cancer women from metastasis

  2016cites this paper
• Effect of insulin analogues on phosphatidyl inositol-3 kinase/Akt signalling in INS-1 rat pancreatic derived β-cells

  2016cites this paper
• Adrenocortical tumors and insulin resistance: What is the first step?

  2016cites this paper
• BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549

  2016cites this paper
• Equine insulin receptor and insulin-like growth factor-1 receptor expression in digital lamellar tissue and insulin target tissues.

  2016cites this paper
• Type 2 diabetes and breast cancer - the role of hyperinsulinaemia in breast cancer development and mortality

  2016cites this paper
• IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma

  2015cites this paper
• The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy

  2015cites this paper
• The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins

  2015cites this paper
• Insulin Analogs: Assessment of Insulin Mitogenicity and IGF-I Activity

  2015cites this paper
• Exploring a therapeutic role for IGF1R inhibitors in triple-negative breast cancer

  2015cites this paper
• The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts

  2015cites this paper
• Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells

  2015cites this paper
• Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation

  2015cites this paper
• Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

  2015influential citation
• Targeting the IGF-1R: The Tale of the Tortoise and the Hare

  2015cites this paper
• Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?

  2015cites this paper
• The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.

  2015cites this paper
• Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

  2015cites this paper
• MULTILEVEL DEREGULATION OF SURVIVAL MECHANISMS IN NPM-ALK+ T-CELL LYMPHOMA

  2015cites this paper
• Mechanisms of Action of Metformin as an Anti-cancer Agent

  2014cites this paper
• Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy

  2014cites this paper
• Expression of insulin-like growth factor receptor type 1 correlate with lymphatic metastases in human gastric cancer.

  2014cites this paper
• Biological Effects of Insulin and Its Analogs on Cancer Cells With Different Insulin Family Receptor Expression

  2014cites this paper
• Targeting anti-apoptotic proteins with small dual binding ligands.

  2014cites this paper
• Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma

  2014cites this paper
• The insulin-like growth factor 1 axis in prognosis and treatment of breast cancer

  2014cites this paper
• ExprEssion of insulin-likE growth factor rEcEptor typE 1 corrElatEs with lymphatic mEtastasEs in human gastric cancEr

  2014cites this paper
• The synergistic effect of humanized monoclonal antibodies targeting insulin-like growth factor 1 receptor (IGF-1R) and chemotherapy.

  2014cites this paper
• Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells

  2014cites this paper
• Development of a Human Breast-Cancer Derived Cell Line Stably Expressing a Bioluminescence Resonance Energy Transfer (BRET)-Based Phosphatidyl Inositol-3 Phosphate (PIP3) Biosensor

  2014cites this paper
• Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

  2014cites this paper
• Insulin receptor signaling in normal and insulin-resistant states.

  2014cites this paper
• Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.

  2014cites this paper
• Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation

  2013cites this paper
• Role of IGF-II, PRL, and FABPs in the Breast Cancer Disparity among AA Women

  2013cites this paper
• The metabolic and mitogenic properties of basal insulin analogues

  2013cites this paper
• Diabetes and cancer relationships (糖尿病与肿瘤的关联性)

  2013cites this paper
• The role of insulin and IGF system in pancreatic cancer.

  2013cites this paper
• Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.

  2013cites this paper
• Title: Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-1 receptor

  2013cites this paper
• The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer

  2013cites this paper
• Insulin-like growth factor-I regulates GPER expression and function in cancer cells

  2013cites this paper
• Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor

  2013cites this paper
• Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B

  2013cites this paper
• Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats

  2013cites this paper
• Pubertal high fat diet: effects on mammary cancer development

  2013cites this paper
• Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab

  2013cites this paper
• Targeting the Notch-1/IGF-1R/Akt Axis in at Orthotopic Model of Advanced Non-Small Cell Lung Cancer

  2013cites this paper
• Insulin has multiple antiamyloidogenic effects on human neuronal cells.

  2013cites this paper
• Weight control and cancer preventive mechanisms: Role of insulin growth factor-1-mediated signaling pathways

  2013cites this paper
• Weight control, endocrine hormones and cancer prevention

  2013cites this paper
• Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis.

  2013cites this paper
• The decline and fall of the IGF‐I receptor

  2013cites this paper
• Construction of antibody/insulin receptor chimera for growth induction of mammalian cells

  2013cites this paper
• Insulin receptor membrane retention by a traceable chimeric mutant

  2013cites this paper
• An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R*

  2013cites this paper
• Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug

  2013cites this paper
• Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer

  2013cites this paper
• A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

  2013cites this paper
• Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling.

  2012cites this paper
• The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis

  2012cites this paper